Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ProPhase Labs, Inc.PRPH · Entity 8699 | Chief Financial Officer | September 29, 2017 | October 02, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ProPhase Labs, Inc.
Report date September 29, 2017 · Filed October 02, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.005SEC Table I · non-derivative | Direct | 132,703 |
Reported balance
After 2017-09-29 transaction · row 1
1 source rowRow 1 · 2017-09-29 · Sale · Disposed 358,621 · Balance 132,703 F1: These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2017 Filed Oct 2, 2017 16:54 UTC | ProPhase Labs, Inc. PRPH · Entity 8699 | SaleCommon Stock, par value $0.005 | 358,621 | $2.30 | $824,828.30 |
DisclosureSEC source: 0001493152-17-011127 · form4.xml · nonDerivative · entry 1 CUDDIHY ROBERT V JR · CIK 0001142043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,703 F1 · shares: These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 20:40 UTC | ProPhase Labs, Inc. PRPH · Entity 8699 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001493152-17-010672 · form4.xml · derivative · entry 6 CUDDIHY ROBERT V JR · CIK 0001142043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2021-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 20:40 UTC | ProPhase Labs, Inc. PRPH · Entity 8699 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001493152-17-010672 · form4.xml · derivative · entry 5 CUDDIHY ROBERT V JR · CIK 0001142043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2019-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 20:40 UTC | ProPhase Labs, Inc. PRPH · Entity 8699 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001493152-17-010672 · form4.xml · derivative · entry 4 CUDDIHY ROBERT V JR · CIK 0001142043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2017-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 20:40 UTC | ProPhase Labs, Inc. PRPH · Entity 8699 | Exercise / conversionCommon Stock, par value $0.005 | 40,000 | $1.39 | $55,600.00 |
DisclosureSEC source: 0001493152-17-010672 · form4.xml · nonDerivative · entry 3 CUDDIHY ROBERT V JR · CIK 0001142043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 20:40 UTC | ProPhase Labs, Inc. PRPH · Entity 8699 | Exercise / conversionCommon Stock, par value $0.005 | 120,000 | $1.65 | $198,000.00 |
DisclosureSEC source: 0001493152-17-010672 · form4.xml · nonDerivative · entry 2 CUDDIHY ROBERT V JR · CIK 0001142043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 20:40 UTC | ProPhase Labs, Inc. PRPH · Entity 8699 | Exercise / conversionCommon Stock, par value $0.005 | 200,000 | $1.00 | $200,000.00 |
DisclosureSEC source: 0001493152-17-010672 · form4.xml · nonDerivative · entry 1 CUDDIHY ROBERT V JR · CIK 0001142043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.